Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus placebo for endometrial thickness in endometriosis patients undergoing IVF
IRCT20091012002576N26Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of letrozole in endometriosis and infertility, sponsored by Tehran University of Medical Sciences. Primary endpoint: Clinical pregnancy. Started Sep 2022; status: completed.
02
Drugs
letrozole
03
Conditions
endometriosisinfertility
Beyond the preview
Go deeper on IRCT20091012002576N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N26.